
Navaqure Pharma Llp
Founded in 2021 and headquartered in Madhya Pradesh, India.
Founded in 2021 and headquartered in Madhya Pradesh, India.
Navaqure Pharma Llp (NPL) is 3 Year, 3 Months old Limited Liability Partnership 17 November 2021. Its registered office is in Indore, Madhya Pradesh, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Indore, Madhya Pradesh, India
+91-XXXXXXXXXX
-
AAZ-5185
17 Nov 2021
31 Mar 2023
Roc-Gwalior
Limited Liability Partnership
Name | Designation | Appointment Date | Status |
---|---|---|---|
Amreen Kapadia ![]() | Designated Partner | 17-Nov-2021 | Current |
Aman Rajoria ![]() | Designated Partner | 17-Nov-2021 | Current |
Enhance accessibility to Navaqure Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Navaqure Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
There are no Open Charges registered against the LLP as per our records.
Unlock and access historical data on people associated with Navaqure Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Navaqure Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Navaqure Pharma Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Navaqure Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with RoC-Gwalior.
Amreen Kapadia was appointed as a Designated Partner was appointed as a Designated Partner on 17 Nov 2021 & has been associated with this company since 3 years 3 months .
Aman Rajoria was appointed as a Designated Partner was appointed as a Designated Partner on 17 Nov 2021 & has been associated with this company since 3 years 3 months .
Navaqure Pharma Llp was registered on 17 Nov 2021 with RoC-Gwalior & aged 3 years 3 months as per MCA records.
Navaqure Pharma Llp was incorporated on 17 Nov 2021.
The Obligation of Contribution of Navaqure Pharma Llp is ₹ 0.10 M.
Currently 2 partners are associated with Navaqure Pharma Llp.
As per Ministry of Corporate Affairs (Mca), the registered address of Navaqure Pharma Llp is H.No. 215 Sch No-114-Pratham, Mp- Vijay Nagar, Indore, Madhya Pradesh, India, 452010.
The Limited Liability Partnership Identification Number (LLPIN) of Navaqure Pharma Llp is AAZ-5185.
The most recent Balance Sheet for Navaqure Pharma Llp was filed with the ROC on 31 Mar 2023.